Výsledky vyhledávání - "Kristel Engelen"

P1-07-06: High Concordance of Protein (by IHC), Gene (by FISH; HER-2 Only) and Microarray Readout (by TargetPrint) of ER/PR/HER2: Results from the MINDACT Trial

Autor: Fatima Cardoso, G. Viale, Annuska M. Glas, Patrizia Dell'Orto, Leila Russo, Jan Bogaerts, Snoo F de, E.J.T. Rutgers, Veer L van't, M.J. Piccart, Kristel Engelen

Publikováno v: Cancer Research. 71:P1-07

Background Previously, the micro-array readout of ER, PR and HER2 by TargetPrint was shown to be strongly correlated with high quality immunohistochemistry (IHC)/FISH assessment, especially for ER and HER2. Concordance rates were 93% (k=0.79) for ER;

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40aa6dab43019c94bd05a12657504f6a
https://doi.org/10.1158/0008-5472.sabcs11-p1-07-06

Zobrazit plný text záznamu

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032)

Autor: Robert M. Conry, Cornelis J. A. Punt, Alain Spatz, Caroline Robert, Alexander M.M. Eggermont, John A. Thompson, Sanjiv S. Agarwala, Neville Davidson, Wim H. J. Kruit, Stefan Suciu, Laurent Mortier, Kristel Engelen, Wen-Jen Hwu, Uwe Trefzer, Reinhard Dummer, Juergen C. Becker, Ulrich Keilholz, Dirk Schadendorf, Poulam M. Patel

Publikováno v: European Journal of Cancer, 47, 10, pp. 1476-83
European Journal of Cancer, 47(10), 1476-1483. Elsevier Ltd.
European journal of cancer (Oxford, England, 47(10), 1476-1483. Elsevier Limited
European Journal of Cancer, 47, 1476-83

Purpose: To compare the efficacy of an extended schedule escalated dose of temozolomide versus standard dose dacarbazine in a large population of patients with stage IV melanoma. Patients and methods: A total of 859 patients were randomised to receiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd07b99153cebb9cd1ad4c06096811b3
https://pubmed.ncbi.nlm.nih.gov/21600759

Zobrazit plný text záznamu

Comparison of molecular (BluePrint and MammaPrint) and pathological subtypes for breast cancer among the first 800 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial

Autor: Giuseppe Viale, Leen Slaets, Femke De Snoo, Laura J. van 't Veer, Emiel J. Rutgers, Jan Bogaerts, Lisette Stork-Sloots, Kristel Engelen, Leila Russo, Patrizia Dell'Orto, Fatima Cardoso, Martine J. Piccart-Gebhart

Publikováno v: Journal of Clinical Oncology. 30:32-32

32 Background: Biology has become the main driver of breast cancer therapy. Intrinsic biological subtypes by gene expression profiling have been identified. Pathology can be used to define surrogates of these subtypes but these are not always concord

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::20b1a45224251cc5e16a783d4110dbae
https://doi.org/10.1200/jco.2012.30.27_suppl.32

Zobrazit plný text záznamu

Comparison of molecular (BluePrint+MammaPrint) and pathological subtypes for breast cancer among the first 800 patients from the EORTC 10041/BIG 3-04 (MINDACT) trial

Autor: Fatima Cardoso, Patrizia Dell'Orto, Laura J. van't Veer, Martine Piccart-Gebhart, Lisette Stork-Sloots, Jan Bogaerts, Kristel Engelen, Leen Slaets, Femke De Snoo, Emiel J. Th. Rutgers, Leila Russo, Giuseppe Viale

Publikováno v: Journal of Clinical Oncology. 30:1022-1022

1022 Background: Biology has become the main driver of breast cancer therapy. Intrinsic biological subtypes by gene expression profiling have been identified. Pathology can be used to define surrogates of these subtypes but these are not always conco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::247c79c71769522c0e5e44b8b4e68270
https://doi.org/10.1200/jco.2012.30.15_suppl.1022

Zobrazit plný text záznamu

The EORTC 10041/BIG 03–04 MINDACT (Microarray in Node Negative and 1 to 3 Positive Lymph Node Disease May Avoid ChemoTherapy) Trial: Patients' Baseline Characteristics and Logistics Aspects After a Successful Accrual

Autor: J-Y Pierga, Kristel Engelen, Jan Bogaerts, L van 't Veer, G. Viale, S. Delaloge, Ulrike Nitz, G. Werutsky, E.J.T. Rutgers, Isabel T. Rubio, Fatima Cardoso, M.J. Piccart, A. Thompson, Rodolfo Passalacqua, Camilo Moulin, Peter Vuylsteke

Publikováno v: European Journal of Cancer. 47:7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::87e97efbd1534f8bb2820e14ed8d2aed
https://doi.org/10.1016/s0959-8049(11)70109-5

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání